Approval · Notice of Compliance 5522 · 1994
STADOL NS: Notice of Compliance 5522
Issued July 7, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5522
- Date
- July 7, 1994
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STADOL NS | 02113031 | Cancelled Post Market |
Medicinal ingredients
- BUTORPHANOL TARTRATE 10 MG per ML